Allied healthCase studyMedical office administration

Pharmaceutical rep and EHR interoperability case

Part A is about who controls access to the physician's time and who may accept a delivery; part B is about data that cannot follow the patient. They are separate problems and the answer should not blur them.

Aug 15, 2026

Editorial process

Last reviewed · August 15, 2026

Written by

Aaron Bishop

MA, Education

assignment interpretation and research-methods coaching across disciplines

Reviewed by

Dr. Nathan Cole

PhD, Rhetoric & Composition

Argumentation and thesis development

On this page

Interpret the task
Assignment instructions
Deliverables
Proposed outline
Research plan
Reference shortlist
Final review

Two parts, two different problems: pressure and interoperability

Part A is a question about role authority, not about whether the representative is being rude. Each of its five sub-questions has a different answer and they should be answered separately. The waiting room is full because a complicated spinal fusion overran, so the scheduled patients have a prior claim on the physician's time and an unscheduled visitor does not displace them — that is the whole of the first two answers, and it holds regardless of the representative's manner. The third and fourth sub-questions are traps worth naming: the fact that Dr. Henderson usually welcomes samples, and the fact that stock is low, are reasons the visit is convenient rather than reasons it should interrupt care. Convenience is not authority. Saying that explicitly is what shows you understood the question rather than sympathised with the office, which is where most answers to this case end up.

The fifth sub-question is the one with a real answer in law and policy. Whether a medical assistant may accept delivery turns on what is being delivered: several of the named samples are ordinary prescription drugs, but Tylenol with codeine is a controlled substance, and controlled substances carry recordkeeping and custody requirements that ordinary samples do not. Check your own state's rules and your practice's policy rather than answering from general principle. Part B is a different problem entirely — Dr. Jonas is not facing an ethical conflict but a technical and regulatory one, where three systems hold fragments of the same patient's record and cannot exchange them. Answer it in those terms: interoperability standards, the burden of learning three interfaces, the patient safety risk when a medication list is incomplete at the point of admission, and the documented relationship between interface burden and clinician burnout, which turns a usability complaint into a workforce argument.

Likely learning objectives

Inferred from the brief — check these against your own rubric.

01
Distinguish role authority from convenience when managing access to a physician's time.
02
Identify the additional handling requirements that attach to controlled substances.
03
Explain interoperability as a technical and safety problem rather than an inconvenience.

Assignment instructionsQuoted verbatim

Read the full question

Review every instruction before using the planning guidance that follows.

Part A: A pharmaceutical representative has just arrived at the office of Dr. Joseph Henderson, a board-certified orthopedic surgeon. The waiting room is swarming with patients waiting to see Dr. Henderson, because he was delayed with an unexpectedly complicated lumbar spinal fusion and laminectomy. The representative is very insistent, almost belligerent, about seeing the physician immediately, even though she did not have an appointment to see him. In fact, the visit was totally unexpected, as the representative had just been in two weeks ago. Last time the representative was in, she gave Dr. Henderson a variety of readily usable and dispensable medications. She has more of the same today—injectable cortisone with Novocain, muscle relaxants, NSAIDs, and even some Tylenol with codeine. Usually, Dr. Henderson is quite receptive to receiving these samples, as they help ease the financial burden on his patients for whom he uses or to whom he dispenses these samples. The office is, in fact, running quite low on these particular medications because of Dr. Henderson’s heavy patient load. Provide detailed answers for each of the following questions. Your response should be at least 150 words in length. · What is your response to the sales representative? · Should a sales representative ever take precedence over scheduled appointments? · Does the fact that Dr. Henderson is usually quite anxious to receive any and all samples for his patients enter in as a factor? · Does the diminished supply of these samples alter the situation? · Can the medical assistant ever accept delivery of any or all of these samples? Part B: Dr. Jonas runs a private practice. He admits patients and makes rounds in two local hospitals. He uses one type of EHR software in his private office and two other packages in the two hospitals. Not only must Dr. Jonas learn three software systems, but he also may at times be unable to move patient information between those systems because of incompatibility. What might Dr. Jonas do to address these issues? Your response should be at least 100 words in length. Part C: Lisa Medina, a certified coder, performs medical coding for a large multi-specialty clinic. You have just been hired as Lisa’s assistant. She has asked you to review the encounter forms for the day, on which physicians have checked off the diagnoses of each patient. You notice that Dr. Parker, an endocrinologist, has checked off the box for Diabetes unspecified for most of his patients without checking off any manifestations or complications. You think this is unusual because many diabetic patients do have complications. Provide detailed answers for each of the following questions. Your response should at least 150 words in length. · What are the options for handling this situation? · Which option would you select? Give three reasons for your choice. · With whom should you consult before acting on your choice? Part D: Sarah Egan is the office manager in Dr. Williams’s practice. Nell Jacobs, who has worked as a CMA (AAMA) in the office for one year, has frequently been absent or tardy on Mondays. Sarah suspects that Nell has a drinking problem. However, Nell has never arrived at the office intoxicated—until today. Sarah has just observed Nell stumbling in the parking lot when getting out of her car. Her speech is slurred, and her breath has a fruity odor that Sarah thinks could be alcohol. Nell does not appear to understand anything that Sarah is saying to her. Provide detailed answers for each of the following questions. Your response should at least 250 words in length. · Given the situation, as the office manager, what should Sarah do immediately regarding Nell? · If Sarah decides to send Nell home, should she call Nell’s husband to come and get her, or, perhaps, insist that Nell go home in a cab? · Does Sarah have an obligation to tell Dr. Williams about her suspicions regarding Nell? Discussion: A pharmaceutical representative · Should this incident become part of Nell’s employment record? · Is this incident grounds for firing an employee? · Because Nell is a CMA (AAMA) and works with patients, is it within Sarah’s rights to demand a blood and urine screening for alcohol and drugs? · Should the police be notified of the incident? · If Nell is indeed intoxicated or under the influence of alcohol, is Sarah obligated to refer Nell to counseling at an alcohol and drug rehabilitation facility?

Turn the brief into deliverables

01
Responses of at least 150 words to each Part A question.
02
An answer on sample acceptance that distinguishes controlled from non-controlled drugs.
03
A Part B discussion covering learning burden, data exchange and patient safety.
04
APA citations to a professional opinion and an interoperability source.

Answering the five rep questions, then Dr. Jonas

Respond to the representative

State the professional response and ground it in the scheduled patients' prior claim on the physician's time.

Precedence, welcome and low stock

Answer the second, third and fourth questions, treating convenience as distinct from authority.

Sample acceptance and controlled substances

Distinguish ordinary samples from the controlled substance in the list and state what changes.

Dr. Jonas and interoperability

Describe the three-system problem in terms of data exchange, standards and incomplete records.

What would actually help

Name realistic mitigations — health information exchange participation, reconciliation at admission, standard interfaces.

Professional opinions and interoperability standards

Recommended databases

AMA Code of Medical Ethics
Office of the National Coordinator for Health IT
DEA controlled substance regulations
Your state medical board
PubMed Central

Search sequence

1.
Read the AMA opinion on industry gifts and samples before answering Part A; it addresses the situation directly.
2.
Check the DEA schedule for codeine combination products so the controlled substance answer is precise rather than assumed.
3.
Use the ONC interoperability pages for the standards vocabulary Part B needs.
4.
Look for evidence linking system fragmentation to clinician burden, which strengthens the Part B argument.

Reference shortlist

These are authoritative starting points, not a ready-made bibliography. A qualified reviewer must confirm that each source fits the assignment and supports the claim beside which it is cited.

Nothing here is cleared for citation until you have read it.

01
Gifts to Physicians from Industry
American Medical Association · 2024
The profession's own opinion on industry gifts and samples, which is the standard the Dr. Henderson half of this case is measured against.
02
Interoperability
Office of the National Coordinator for Health Information Technology · 2024
Defines the exchange problem Dr. Jonas faces across three systems, and names the standards intended to resolve it.
03
The association between perceived electronic health record usability and professional burnout among US nurses
Journal of the American Medical Informatics Association, 28(8), 1632-1641 · 2021
Measured evidence that interface burden has clinician consequences, which is the empirical half of the Part B argument.
04
About CAHPS
Agency for Healthcare Research and Quality · 2024
A model of how a standardised instrument is designed, validated and reported, which is what turns a screening intention into a measurable process.

Review before submission

Common mistakes

Answering Part A on the basis of the representative's behaviour rather than on scheduling authority.
Treating low stock or the physician's usual welcome as a reason to interrupt patient care.
Giving one blanket answer on sample acceptance without separating controlled substances.
Reducing Part B to 'learning three systems is hard' and missing the patient safety consequence.

Submission checklist

Is each of the five Part A questions answered separately?
Have you identified Tylenol with codeine as a controlled substance with different rules?
Does Part B address data exchange and not just user inconvenience?
Are professional or regulatory sources cited rather than opinion?

Use this guide to plan and review your own work. Follow your institution's rules and read our academic-integrity policy.